Latest 13F institutional holdings

Barclays Bank PLC reports no holdings for the quarter ending December 31, 2024, in its latest 13F filing.

Janus Henderson Group PLC's latest 13F filing discloses its holdings as of December 31, 2024, showcasing a diverse portfolio valued at over $196 billion.

Ameriprise Financial Inc.'s latest 13F filing discloses its holdings as of December 31, 2024, showcasing a diverse investment portfolio.

AlTi Global, Inc. reports its Q4 2024 holdings, revealing significant positions in various equities and ETFs with a total value of approximately $4.14 billion.

Sanofi's latest 13F filing reveals substantial investments in several biotechnology companies, including MeiraGTx Holdings plc and Novavax.

Hancock Whitney Corp's latest 13F filing reveals significant investment positions across diverse sectors as of December 31, 2024, totaling approximately $3.16 billion.

Merck & Co., Inc. reports its holdings for the quarter ended December 31, 2024, revealing significant investments in various biotechnology and pharmaceutical companies.

Voya Financial, Inc. filed a 13F notice indicating no holdings were reported for the quarter ending December 31, 2024, with all holdings reported by other managers.

Toyota Motor Corp's latest 13F filing reveals significant investments in U.S.-listed companies, totaling approximately $2.95 billion as of December 31, 2024.

Axon Enterprise, Inc. reports holding $198.3 million in Cellebrite DI Ltd. Ordinary Shares as of December 31, 2024.

Banco Bilbao Vizcaya Argentaria, S.A. discloses its Q4 2024 equity holdings, with substantial investments in NVIDIA, Microsoft, and Apple.

UBS Group AG's latest 13F-HR filing reveals a vast and diversified portfolio, with significant investments across various sectors and asset classes.

State Street Corp's latest 13F filing unveils its substantial holdings, totaling over $2.5 trillion as of December 31, 2024, distributed across 4,297 positions.

UBS AG reports no holdings for the quarter ending December 31, 2024, according to its latest 13F filing.

NVIDIA Corp's latest 13F filing reveals its equity holdings as of December 31, 2024, totaling $304.5 million across five companies.

Fairfax Financial Holdings' latest 13F filing discloses its equity holdings as of December 31, 2024, totaling over $1.5 billion across 31 positions.

DigitalBridge Group, Inc. discloses its holdings as of December 31, 2024, in a recent Form 13F filing, showcasing a diverse investment portfolio valued at over $1.3 billion.

First Commonwealth Financial Corp /PA/ discloses its holdings as of December 31, 2024, with a total value of $424 million.

Ventas, Inc. reports a $159.6 million investment in Ardent Health Partners as of December 31, 2024.

Cohen & Steers, Inc. reports its holdings for the quarter ended December 31, 2024, revealing a total portfolio value of over $52.8 billion across 409 holdings.

Carlyle Group Inc. reports its holdings for the quarter ended December 31, 2024, revealing a total portfolio value of approximately $4.15 billion across 27 positions.

CVS Health Corp's recent 13F filing reveals its holdings in Prudential Financial, Health Catalyst, and SPDR S&P 500 ETF Trust as of December 31, 2024.

Teton Advisors, Inc. reports its holdings for the quarter ended December 31, 2024, with a total portfolio value of $195.1 million.

Affiliated Managers Group (AMG) filed a 13F notice for the quarter ended December 31, 2024, indicating that its affiliated investment management firms independently manage their holdings and AMG disclaims beneficial ownership.

Ally Financial Inc.'s latest 13F filing reveals its holdings as of December 31, 2024, showcasing a diverse portfolio of stocks and ETFs valued at approximately $820 million.

Finward Bancorp's latest 13F filing reveals its holdings as of December 31, 2024, with a total portfolio value of $115.34 million.

Manulife Financial Corp files a 13F notice indicating no holdings were reported for the quarter ending December 31, 2024, with all holdings reported by other reporting managers.

Gilead Sciences' latest 13F filing discloses its equity holdings as of December 31, 2024, showcasing significant investments in various biotechnology companies.

Fidelity National Financial's latest 13F filing reveals a diverse portfolio of holdings valued at approximately $4.95 billion as of December 31, 2024.

Cadence Bank's recent 13F filing reveals a diverse portfolio of 591 holdings valued at approximately $1.48 billion as of December 31, 2024.